Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitusJia Liu, Mengzhao Wang, Haoran Zhang et al.|Translational Oncology|2022Cited by 25
Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational studyYuequan Shi, Mengzhao Wang, Anwen Liu et al.|Chinese Medical Journal|2025Cited by 1